| Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment WB Fang, M Yao, G Brummer, D Acevedo, N Alhakamy, C Berkland, ... Oncotarget 7 (31), 49349, 2016 | 126 | 2016 |
| Cytokine regulation of metastasis and tumorigenicity M Yao, G Brummer, D Acevedo, N Cheng Advances in cancer research 132, 265-367, 2016 | 109 | 2016 |
| CCR2 chemokine receptors enhance growth and cell-cycle progression of breast cancer cells through SRC and PKC activation M Yao, W Fang, C Smart, Q Hu, S Huang, N Alvarez, P Fields, N Cheng Molecular Cancer Research 17 (2), 604-617, 2019 | 65 | 2019 |
| Carcinomas assemble a filamentous CXCL12–keratin-19 coating that suppresses T cell–mediated immune attack Z Wang, P Moresco, R Yan, J Li, Y Gao, D Biasci, M Yao, J Pearson, ... Proceedings of the National Academy of Sciences 119 (4), e2119463119, 2022 | 59 | 2022 |
| Chemokine signaling facilitates early-stage breast cancer survival and invasion through fibroblast-dependent mechanisms G Brummer, DS Acevedo, Q Hu, M Portsche, WB Fang, M Yao, B Zinda, ... Molecular Cancer Research 16 (2), 296-308, 2018 | 52 | 2018 |
| The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells WB Fang, M Yao, I Jokar, N Alhakamy, C Berkland, J Chen, ... Breast cancer research and treatment 150, 309-320, 2015 | 40 | 2015 |
| Priming cancer cells for drug resistance: role of the fibroblast niche WB Fang, M Yao, N Cheng Frontiers in biology 9, 114-126, 2014 | 40 | 2014 |
| TGF-β negatively regulates CXCL1 chemokine expression in mammary fibroblasts through enhancement of Smad2/3 and suppression of HGF/c-Met signaling mechanisms WB Fang, B Mafuvadze, M Yao, A Zou, M Portsche, N Cheng PloS one 10 (8), e0135063, 2015 | 36 | 2015 |
| Elevated expression of chemokine CC ligand 2 in stroma is associated with recurrent basal-like breast cancers M Yao, E Yu, V Staggs, F Fan, N Cheng Modern Pathology 29 (8), 810-823, 2016 | 35 | 2016 |
| Role of ALDH1A1 and HTRA2 expression in CCL2/CCR2-mediated breast cancer cell growth and invasion Q Hu, M Myers, W Fang, M Yao, G Brummer, J Hawj, C Smart, C Berkland, ... Biology open 8 (7), bio040873, 2019 | 26 | 2019 |
| Continuous delivery of neutralizing antibodies elevate CCL2 levels in mice bearing MCF10CA1d breast tumor xenografts M Yao, C Smart, Q Hu, N Cheng Translational Oncology 10 (5), 734-743, 2017 | 26 | 2017 |
| Plasma cells in human pancreatic ductal adenocarcinoma secrete antibodies against self-antigens M Yao, J Preall, JTH Yeh, D Pappin, P Cifani, Y Zhao, S Shen, P Moresco, ... JCI insight 8 (21), e172449, 2023 | 8 | 2023 |
| Pancreatic cancer cells assemble a CXCL12-keratin 19 coating to resist immunotherapy Z Wang, R Yan, J Li, Y Gao, P Moresco, M Yao, JF Hechtman, MJ Weiss, ... bioRxiv, 776419, 2019 | 5 | 2019 |
Cory BerklandWashington University in Saint LouisVerified email at wustl.edu
